Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience Receives NASDAQ Delinquency Notice
HOLLISTON, Mass., March 17, 2016 (GLOBE NEWSWIRE) -- On March 16, 2016, Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, received a notice from NASDAQ (the "Notice") stating the Company is
View HTML
Toggle Summary Harvard Bioscience Announces Delay in Filing Form 10-K
Reports Delay is Result of Forensic Investigation Following Minor Employee Theft Will schedule conference call to discuss fourth quarter and full year 2015 results upon completion of the investigation HOLLISTON, Mass., March 14, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc.
View HTML
Toggle Summary Harvard Bioscience Reports Third Quarter 2015 Financial Results and Updates Outlook for Full-Year 2015
Conference Call to be Held at 8:30 AM ET Today
View HTML
Toggle Summary Harvard Bioscience to Showcase Array of New Products at Society for Neuroscience 2015 Annual Meeting in Chicago on October 18-21
Three Symposium Events Highlight Newest Electrophysiology Research Tools
View HTML
Toggle Summary Harvard Bioscience Schedules Third Quarter 2015 Conference Call for October 29 at 8:30 AM ET
HOLLISTON, Mass., Oct. 15, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2015 before market trading hours on Thursday, October 29,
View HTML
Toggle Summary Harvard Bioscience Q2 2015 Revenues Increase 7% Year-over-Year, 12% in Constant Currency, to $28.8 Million
-Conference Call To Be Held at 8:30 AM ET Today- HOLLISTON, Mass., July 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported financial highlights for the three and six
View HTML
Toggle Summary Harvard Bioscience Schedules Second Quarter 2015 Conference Call for July 30 at 8:30 AM ET
HOLLISTON, Mass., July 16, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2015 before market trading hours on Thursday, July 30, 2015.
View HTML
Toggle Summary Harvard Bioscience to Join the Russell 3000 and Russell Global Indexes
HOLLISTON, Mass., June 23, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is set to simultaneously join two broad-market Russell indexes.
View HTML
Toggle Summary Harvard Bioscience Reports First Quarter 2015 Financial Results
Conference Call to be Held at 11:00 AM ET Today
View HTML
Toggle Summary Harvard Bioscience Appoints James Green to the Board of Directors and Announces Retirement of Robert Dishman From the Board
HOLLISTON, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed James Green as a Class I director of the Board of Directors to fill the new
View HTML